Global Saliva Collection Devices Market Size By Type (Whole Saliva Collection Devices, Glandular Saliva Collection Devices), By Application (Pharma and Biotech Companies, Forensics), By Region, And Se...

The Global Saliva Collection Devices Market was valued at USD 2.1 billion in 2023 and is projected to reach USD 4.6 billion by 2031, expanding at a CAGR of 10.3% during the forecast period from 2023 to 2031. This market is driven by the increasing demand for non-invasive diagnostic methods, the growing prevalence of infectious and genetic diseases, and the rising application of saliva-based testing in personalized medicine and telehealth services. Saliva collection devices are becoming vital tools in clinical diagnostics, enabling convenient sample collection, storage, and transportation, especially in decentralized healthcare and at-home testing environments.

Drivers:

1. Shift Toward Non-Invasive Diagnostics:

Saliva offers a painless, easy-to-collect alternative to blood samples, encouraging the uptake of saliva collection devices in both clinical and home settings.

2. Rise in At-Home and Remote Testing:

The growing telehealth ecosystem and demand for self-collection kits for COVID-19, hormonal, genetic, and drug testing are propelling market expansion.

3. Advancements in Genomics and Personalized Medicine:

Saliva is increasingly being used in DNA analysis and pharmacogenomics, pushing forward demand for high-integrity collection tools.

Restraints:

1. Variability in Sample Quality:

Differences in saliva composition and volume due to individual biological variability or improper sample collection may hinder diagnostic accuracy.

2. Limited Reimbursement Policies:

In many regions, the lack of reimbursement for saliva-based testing limits the widespread adoption of these devices, particularly in clinical settings.

Opportunity:

1. Growth in Preventive Healthcare and Population Screening Programs:

Public health agencies and governments are increasingly relying on saliva-based tests for mass screening due to their scalability and cost-effectiveness.

2. Emerging Applications in Oncology and Neurology:

Ongoing research into saliva biomarkers for cancer and neurodegenerative diseases opens new frontiers for product development and market penetration.

Market by System Type Insights:

By system type, the Saliva Collection Kits segment dominated the market in 2023. These kits, which include devices with stabilizing agents, have seen widespread use in infectious disease testing, genetic testing, and substance abuse monitoring. The Saliva Collection Swabs segment is anticipated to witness robust growth due to their ease of use and cost-effectiveness in rapid screening programs.

Market by End-Use Insights:

In 2023, the Diagnostic Laboratories segment held the largest market share due to the widespread integration of saliva-based assays in laboratory diagnostics. The Home Care Settings segment is projected to grow at the highest CAGR during the forecast period, driven by the demand for convenient and private sample collection methods in consumer health testing.

Market by Regional Insights:

North America led the global saliva collection devices market in 2023, driven by advanced healthcare infrastructure, a surge in FDA approvals for saliva-based tests, and strong consumer awareness. Asia-Pacific is expected to be the fastest-growing region due to increasing healthcare investments, expanding molecular diagnostics market, and government support for public health testing initiatives.

Competitive Scenario:

Key players operating in the global saliva collection devices market include DNA Genotek Inc. (an OraSure Technologies company), Thermo Fisher Scientific Inc., Salimetrics LLC, Neogen Corporation, Spectrum Solutions LLC, Puritan Medical Products, and Oasis Diagnostics Corporation. Strategic partnerships, product innovation, and acquisitions are shaping competitive dynamics. Notable developments include:

In 2023, Spectrum Solutions launched a next-generation saliva DNA collection kit with enhanced stabilization for high-throughput genomic analysis.

In 2024, DNA Genotek expanded its global footprint by partnering with diagnostics labs in Asia-Pacific for scalable at-home testing solutions.

In 2025, Salimetrics introduced a portable saliva collection platform aimed at pediatric and elderly patients, enhancing user comfort and sample compliance.

Scope of Work – Global Saliva Collection Devices Market

Report Metric Details

Market Size (2023) USD 2.1 Billion

Projected Market Size (2031) USD 4.6 Billion

CAGR (2023–2031) 10.3%

Market Segments System Type (Kits, Swabs), End-use (Diagnostics, Home Care, Others)

Growth Drivers Rise in non-invasive diagnostics, at-home testing demand

Opportunities Expansion in preventive screening, oncology applications